Rheumatoid factor (RF) is an important marker of many autoimmune diseases. Presence of RF is characteristic for rheumatoid arthritis and other inflammatory diseases of various underlying aetiologies.
this method is rapid, does not require special equipment, a small volume of sample is taken into analysis and the cost per test is relatively low.
In 1992 Nielsen described an ELISA assay applicable to RF-IgM detection in canine serum; this author also confirmed that the WHO standard of human RF-IgM was suitable as a quality control for the method (Nielsen 1992) . A British team led by Bell also applied the ELISA method not only to RF-IgM detection, but also to RF-IgA detection both in serum and in SF, (Bell et al. 1993 ). Our study is based on their findings. RF-IgM and RFIgA were determined in a similar way in another publication (Chabanne et al. 1993) .
The aim of our study was the optimisation of the ELISA method for RF-IgM detection. ELISA is a rapid, simple method, which has been used in the laboratory of the Veterinary Research Institute (VRI). The initial methodology was based on the study of Bell et al. (1993) . Subsequently, we used the optimised ELISA for examination of sera from diseased and healthy dogs and we investigated whether the between-group differences in RF-IgM values were significant.
Materials and Methods

Animals
We examined a total of 80 serum samples; 60 samples were obtained from dogs with a clinically detectable disease, patients of the Clinic for Diseases of Dogs and Cats, University of Veterinary and Pharmaceutical Sciences Brno, and from veterinary practitioners. The remaining 20 samples were collected from clinically healthy donor dogs (beagles from the breeding colony of VRI), from other dogs (e.g. presented for routine vaccination) at the Clinic for Diseases of Dogs and Cats, University of Veterinary and Pharmaceutical Sciences Brno, from military working dogs of the Armed Forces of the Czech Republic; and some family-owned dogs were also included. The structure of breeds included in our study reflected the breeds most commonly found in the Czech Republic -the German Shepherd Dog, Beagle, Cocker Spaniel, Dachshund, Rottweiler, Bull Terrier, Doberman Pincher, American Staffordshire Terrier and also crossbreeds.
A serum sample from a dog with non-erosive polyarthritis served as a positive control; this control had repeatedly shown high absorbance during previous experimental testing by LFT. Mixed sera from newborn beagles were used as a negative control.
Four groups of dogs were studied. Dogs suffering from a variety of medical and surgical conditions were allocated to one of three groups according to the results of their clinical examination, radiographic and laboratory investigation (haematology, biochemistry and serology); the fourth group comprised control healthy dogs (without lameness, pain, physical or radiographic findings in the musculoskeletal system and no signs of any other disorders).
An important factor in the basic diagnostics of immune-mediated polyarthritis in dogs is the assessment of serum antinuclear antibodies (ANA) reactivity which is supposed to contribute to the exclusion of systemic lupus erythematosus (Day 1999) . Hence, ANA test result served as one of the criteria for the distribution of dogs into corresponding groups.
Group I -dogs positive in the ANA test (ANA+) suffering from orthopaedic or complex diseases (diseases involving multiple organ systems) included 23 dogs with diagnosed non-erosive polyarthritis (19 cases) and erosive polyarthritis (1 case) or systemic lupus erythematosus (3 cases), with a positive result for the ANA test at the titre of 1 : 100 and greater. The age ranged between 1.5 and 11 years (the median was 4 years; the mean was 4.2 years), there were 12 males, 10 females and 1 spayed female.
Group II -dogs negative in the ANA test (ANA-) suffering from orthopaedic or complex diseases included 19 dogs with diagnosed non-erosive polyarthritis (2 cases), osteoarthritis (6 cases), osteochondrosis (1 case) or cranial cruciate ligament rupture (10 cases) with a negative ANA test. The age ranged between 2.5 and 12 years (the median was 5 years; the mean was 6 years), the sex of the animals was: 11 males, 7 females and 1 neutered male.
Group III -dogs negative in the ANA test (ANA-) suffering from chronic inflammatory diseases included 18 dogs with dermatologic disorders (deep pyoderma -2 cases, demodicosis -1 case, dermatitis mycofungalis -1 case, subcutaneous abscesses -1 case), stomatological disorders (stomatitis -1 case, periodontitis -5 cases, periapical granuloma -3 cases) and gynaecological (pyometra -3 cases, vaginitis -1 case) disorders. The musculoskeletal system was not affected. The age ranged between 1 and 15 years (the median was 7.5 years; the mean was 7 years), there were 10 males and 8 females.
Group IV -healthy control dogs -included 20 clinically healthy individuals. The age ranged between 1 week (the beagle puppies) and 13 years (the median was 5 years; the mean was 5.9 years), there were 9 males, 10 females and 1 spayed female.
Serum samples
Blood was obtained by aseptic venepuncture from the cephalic or jugular vein. After coagulation at room temperature for 2 h, sera were removed from the clots by centrifugation at 600 g for 15 min at room temperature. Sera were then divided into aliquots and stored at -20 °C until required.
Chemicals and equipment
Dog IgG (D IgG) was separated from dog sera by affinity chromatography and purified by gel chromatography at VRI. Dog serum was precipitated using a saturated solution of (NH 4 ) 2 SO 4 up to a total concentration of 33% and subsequently diluted in 50 mM phosphate buffer containing 150 mM NaCl, pH 7.4. Following dialysis against 50 mM phosphate buffer, the supernatant was thickened in an ultrafiltration equipment amicon with PM 10 membrane. The affinity chromatography itself was carried out using FPLC in a column with protein G (Pharmacia) (column 2 ml) and purification was performed in a preparative column Superose 12 (column 270 ml). The purity of the selected fraction was assessed by SDS-PAGE and IELFO.
RF-IgM was detected with a goat anti-canine IgG: horseradish peroxidase conjugate (aD IgM*Px, Bethyl Laboratories Inc., Montgomery, TX, USA). RF-IgM ELISA tests were performed on the Micro-ELISA plates MaxiSorp TM Nunc-Immuno TM Plate (Nalge Nunc International, Roskilde, Denmark, abbreviated as Nunc); alternatively for method optimisation Mikrotitracni desticka P (Gama a. s., Ceske Budejovice, Czech Republic, abbreviated as Gama) was used. The washer WeWASH 4 MK 2 (Denley Instruments LTD, Billingshurst, GB) was used. Intensity of the colour reaction (absorbance) was detected by ELISA-reader IMS READER MF (LABSYSTEMS, Helsinki, Finland) using Genesis 2.0 software (LABSYSTEMS, Helsinki, Finland). If not indicated otherwise, all chemicals were purchased from Sigma (Sigma-Aldrich, Prague, Czech Republic).
RF-IgM ELISA protocol
The RF-IgM ELISA protocol described below was chosen on the basis of testing various reaction conditions and materials and evaluating parameters and reproducibility of calibration curves.
Diluent -phosphate-buffered saline (PBS, pH 7.4), 0.05% Tween 20 and 0.5% enzymatic casein hydrolysate; Washing solution -PBS, pH 7.4, 0.05% Tween 20; Detection system -substrate: hydrogen peroxide (0.03% H 2 O 2 ), chromogen 0.8 mM TMB (tetramethylbenzidine) in 0.1 M acetate buffer, pH 5.6, Test Line Brno, Czech Republic 1. 100 µl of antigen D IgG (0.5 µg/ml PBS), pH 7.4 was dispensed into each well of micro-ELISA plate (Nunc). 2. Antigen was incubated at 37 °C for 1 h (shaking in a thermostat) and then at 4 °C in a refrigerator overnight. 3. Plates were washed (× 3) with washing solution and then 100 µl of serum sample or control sample was added in duplicates into the wells (sera and control samples were pre-diluted 1 : 10 with the diluent). 4. The serum samples were diluted with the diluent: 1 : 100, 1 : 1 000 and 1 : 10 000 and both the controls were diluted threefold: 1 : 30, 1 : 100, 1 : 300, 1 : 1 000, 1 : 3 000, 1 : 10 000 and 1 : 30 000. 5. Samples and controls were incubated at 37 °C for 1 h (shaking in a thermostat). 6. Plates were washed × 3 with washing solution. 7. 100 µl of conjugate aD IgM*Px diluted × 20 000 with the diluents was dispensed into each well. 8. Wells with the conjugate were incubated at 37 °C for 1 h (shaking in the thermostat) and then for 1 h at 4 °C in the refrigerator. 9. Plates were washed × 3 with washing solution. 10. Subsequently, the substrate (H 2 O 2 ) and chromogen (TMB) mixed 1 : 1 were added at a volume of 100 µl to each well. 11. Plates were incubated at room temperature for 15 min. 12. The absorbance (colour reaction) was determined at 450 nm immediately after the addition of 50 µl of 2M H 2 SO 4 (stop solution) to each well. 13. The absorbance values of both controls were used as a base for calibration curve construction. 14. RF-IgM value of each sample was expressed as a percentage of the absorbance relative to the positive control absorbance at an appropriate dilution. The standard serum could also be used for the calibration. Optimisation of RF-IgM ELISA During optimisation of the method, we tested two microtitration plates Nunc and Gama, buffers with pH ranging from 8.6 to 9.6, sample incubation times from overnight to 1 h, different incubation temperatures from 4 °C to 37 °C, antigen concentration 25 µg/ml, 10 µg/ml and 0.5 µg/ml and the effect of blocking the antibody presence/absence. The character of the calibration curve for different concentrations of our positive control sample was the most important criterion for evaluating the method modifications.
Statistical analyses
Statistical and graphic software STAT Plus, VRI Brno (Matoušková et al. 1992 ) was used for statistical evaluation of data. After elimination of the deviating values, normality of basic statistical distribution was investigated using a frequency diagram. If needed, the Box-Cox's transformation was used. Unpaired t-test for equal and unequal variances was performed to test for significant differences between RF-IgM values in different groups. Data in groups were compared to ascertain whether there were significant differences. Finally, multifactor analysis of variance was performed to detect variability. The part of variability caused by measurement errors on three consecutive days was determined.
Results
Reproducibility of RF-IgM ELISA
We analysed data acquired by independent repeated measurements of all 80 canine sera including the positive and negative controls on the Nunc plates on three consecutive days.
The multifactor analysis of variance showed that the part of the data variability which was caused by differences between measurements on three consecutive days, i.e. the degree of reproducibility, was higher at the 1 : 1 000 dilution (variance estimation σ 2 = 59.2) than at 1 : 100 (variance estimation σ 2 = 17.8). The 1 : 100 dilution was evidently associated with a lower measurement error. The measurements were also associated with a lower error at both analysed dilutions if Nunc plates were used instead of Gama plates (σ 2 = 210.2 at the 1 : 100 dilution and σ 2 = 88.9 at the 1 : 1 000 dilution, respectively). Hence, the most reproducible results were obtained at the 1 : 100 dilution when using Nunc plates.
Standard ELISA was monitored using intra-and interassay. Two sera with low absorbance and two sera with high absorbance in 16 replications on one plate were used in the intraassay. Interassay was carried out in 6 replications with four sera (2 with low and 2 with high absorbance), each in triplicates.
Serum dilution as a factor in canine RF-IgM level assessment
We assessed the RF-IgM values obtained at three dilutions of sera (1 : 100, 1 : 1 000, 1 : 10 000) in four groups of dogs according to the above described protocol. There were marked differences between the values of positive and negative controls at 1 : 100 and 1 : 1 000 dilutions (the ratio of values was 6.9 : 1 at the 1 : 100 dilution and 4.1 : 1 at the 1 : 1 000 dilution). The course of the standard curve was of a sigmoid shape at these two dilutions. Differences between the values of positive and negative controls were indistinguishable (1.7 : 1) at the 1 : 10 000 dilution and accordingly, this dilution was not suitable for measurements of the examined samples. Thus we did not perform a detailed statistical analysis for this dilution (1 : 10 000).
Complete comparisons of results obtained with all the dilutions are presented in Fig. 1 . Dilutions of 1 : 100 and 1 : 1 000 proved to be satisfactory. The coefficient of correlation for the whole range of values at the dilution of 1 : 100 measured in intraassay was 14.6%, in interassay 18.5%. Table 1 . After the calculation of percentages relative to positive control absorbance, the lowest mean value was detected in group IV (healthy control), i.e. 71.4. This value was significantly lower (p < 0.01) than the value (80.6) detected in group III (dogs suffering from chronic inflammatory diseases ANA-) the value (91.1) in group II (dogs suffering from orthopaedic or complex diseases ANA-) and the value (96.4) in group I (dogs suffering from orthopaedic or complex diseases ANA+). The second lowest value was noted in group III, i.e. 80.6. This value was significantly lower (p < 0.01) than in group II (91.1) and group I (96.4).
Dilution of 1 : 1 000
RF-IgM results obtained at serum dilution 1 : 1000 are presented in Table 2 . The lowest mean value was again detected in group IV (healthy control), i.e. 35.3. This value was significantly lower (p < 0.01) than the value (44.5) detected in group III (dogs suffering from chronic inflammatory diseases ANA-), the value (52.1) in group II (dogs suffering from orthopaedic or complex diseases ANA-) and the value (55.6) in group I (dogs suffering from orthopaedic or complex diseases ANA+). The second lowest value was again noted in group III, i.e. 44.5. This value was significantly lower (p < 0.01) than in group I (55.6).
Individual RF-IgM values
Even though the investigation of the RF-IgM values in individual animals was not the aim of our study, we obtained some noteworthy results that are presented here. However, due to the fact that some diagnoses may not have been accurate, it is difficult to make definitive conclusions.
A dog with suspected RA showed high RF-IgM values (103.4 at the 1 : 100 dilution, mean value was 96.4 at this dilution) with concurrent positivity in the ANA test. Table 2 . RF-IgM value differences between groups of dogs at serum dilution 1:1000
Group I -dogs suffering from orthopaedic or complex diseases ANA+ Group II -dogs suffering from orthopaedic or complex diseases ANAGroup III -dogs suffering from chronic inflammatory diseases ANAGroup IV -healthy control dogs of them were also positive in the ANA test. Three dogs with a suspected diagnosis of systemic lupus erythematosus had high RF-IgM values (between 83.5 and 100.1 at the 1 : 100 dilution) and a positive ANA test. In the group of animals affected by chronic inflammatory diseases, high RF-IgM values were detected in bitches with spontaneous pyometra (99.1 at the 1 : 100 dilution), with vaginitis (99.3 at the 1 : 100 dilution), in dogs with periodontitis (96.4 at the 1 : 100 dilution), stomatitis (87.7 at the 1 : 100 dilution), repeated respiratory and intestinal tract infections (104.9 at the 1 : 100 dilution) and in a dog with pyoderma (97.9 at the 1 : 100 dilution); contrariwise RF-IgM was low in another case of pyoderma (only 51.1 at the same dilution).
Discussion
At present, RF is not tested routinely in the Czech veterinary laboratories, although the test is commonly available in other countries (Barta 1993; Bell et al. 1993; Chabanne et al. 1993; Day 1999) . Methods based on the agglutination of sensitised particles (RWT and LFT) or ELISA are used for RF detection in serum and SF. ELISA is the most sensitive and specific method (Visser et al. 1996; Wener 2002) . It is a rapid test, easy automation is possible, many samples can be examined simultaneously; quantification of the results and detection of different RF classes by using proper detecting systems is possible and the use of human standard serum is convenient.
The ELISA assay allows detection of various RF classes. However, we preferred detection of RF-IgM because it is present in the highest levels in serum and is generally considered as playing an important role in the pathogenesis of RA.
The initial methodology was based on the study of Bell et al. (1993) but our method was modified markedly during optimisation. Although there is a dissimilar distribution of diagnoses in our study and there are no standardized control samples available, our results are in agreement with previously published data (Bell et al. 1993; Chabanne et al. 1993) .
The final ELISA modification provided an acceptable calibration curve; the curve had a sigmoid shape, sample absorbances approximated to the background values when diluted at 1 : 100 and there was a significant difference between the values of positive vs. negative control.
The dilution of 1 : 100 was associated with a smaller error than the 1 : 1 000 dilution according to the statistical analysis. In practical application of this method, it will be possible to analyse the absorbance values at a dilution higher than 1 : 100, which is associated with a low measurement error, and lower than 1 : 1 000, where the value of negative control approximates the background value.
We detected the highest mean values in group I (dogs suffering from orthopaedic or complex diseases -ANA+) and group II (dogs suffering from orthopaedic or complex diseases -ANA-) at both dilutions used. These mean values were significantly higher than in group III (dogs suffering from chronic inflammatory diseases -ANA-). The mean values in group IV (healthy control) were the lowest at both dilutions.
An interesting finding was that a dog with suspected RA showed high RF-IgM values (103.4 at the 1 : 100 dilution, the mean value was 96.4 at this dilution) with a concurrent positive ANA titre. This fact need not contradict the suspected diagnosis of RA since some cases may be positive for both RF and ANA (Day 1999) .
We can conclude that RF-IgM values rise significantly in individuals with a chronic inflammatory disease in contrast to control healthy dogs. If the disorders (degenerative or inflammatory) were localised in the musculoskeletal system, e.g. in joints, the RF-IgM values were higher than the values of patients with an inflammation localised in other organ systems. Of course, individual differences exist -for example high RF-IgM values were detected in bitches with spontaneous pyometra (99.1 at the 1 : 100 dilution), which was confirmed by another study (Chabanne et al. 1993) ; these limit the applicability of the method to individual diagnosis.
Thoren-Tolling found significantly lower (p < 0.001) absorbance values in the control group of normal dogs compared to a rheumatic disease group when measuring RF-IgM by ELISA (Thoren-Tolling 1990). Bell detected significantly higher RF-IgM values (p < 0.001) in the dogs with systemic lupus erythematosus in comparison with the dogs suffering from RA and normal dogs. However, the dogs with RA had higher levels of RFIgM than normal control dogs and dogs with osteoarthritis. Their conclusions concerning serum RF-IgA also showed significantly elevated levels in the dogs with RA in contrast to the control group (p < 0.05) and its increase in dogs with systemic lupus erythematosus was even more significant (p < 0.001) than in either the control or RA groups (Bell et al. 1993) . In a previous study using radioimunoassay, the same team of authors found that the dogs suffering from RA had an elevated RF-IgM titre in both serum and SF compared to healthy dogs; the elevation was marked in serum. Some increase was observed in dogs suffering from other arthropathies (septic arthritis, osteoarthritis and osteoarthritis secondary to cranial cruciate ligament rupture groups) (Carter et al. 1989) .
There is correlation of the RF titre with the age of beagle puppies classified as normal (group IV). The mean value of 16.7 at the dilution of 1 : 100 at the age of 1 week was found, which corresponded to the negative control value. Values of 46.6 and 74.2 at the age of 5.5 weeks and 4.5 months, respectively (both at the 1 : 100 dilution) were recorded. It remains unclear how the serum level is influenced by colostrum intake in the youngest puppies. It is reported in calves that besides the increasing titres of RF-IgM and RF-IgG with age, RFIgM titre was significantly higher in calves that ingested colostrum (p < 0.001) (Graham et al. 1998) . There is no comparable information for carnivores.
Conclusions from published data would be more consistent if a standard method existed so that all laboratories used the same source of antigen, the same standard serum for calibration and prepared the samples in the same way.
Another factor that can affect the detection of RF is the "hidden" RF (RF masked by an immune complex), which cannot then be detected. The origin of the examined samples (serum vs. SF) is also relevant since RF can sometimes be detected in SF but serum examination is negative (Rovenský et al. 1998) .
Based on the analysis of data acquired by examination of 80 serum samples from control healthy dogs and from dogs with various disorders we found that dogs suffering from orthopaedic or complex diseases and positive for ANA had the highest mean RF-IgM values at both analysed dilutions (1 : 100 and 1 : 1 000), followed by dogs suffering from orthopaedic or complex diseases and negative for ANA while control healthy dogs had the lowest mean values. Considerable individual differences were found within the groups.
It follows that RF can be used as one of the criteria to distinguish between an immunemediated and other types of arthritis but it is not a specific indicator or individual diagnosis of RA and other canine diseases. RF determination gives information about a disease in the patient but the assessment should be considered together with clinical signs and other laboratory findings before making a final diagnosis.
Standardizace ELISA pro detekci reumatoidního faktoru IgM v krevním séru psů
Revmatoidní faktor (RF) je významným markerem řady autoimunitních onemocnění. Jeho přítomnost je charakteristická pro revmatoidní artritidu a další zánětlivá onemocnění nejrůznější etiologie.
Cílem naší práce bylo zavést a standardizovat vhodnou metodu pro stanovení RF-IgM v psím séru a tuto metodu otestovat na souboru vybraných psů. Zvolili jsme metodu ELISA pro její vysokou specifitu, selektivitu a optimální kvalitu s ohledem na využití v klinické praxi.
Po úspěšné standardizaci jsme touto metodu vyšetřili soubor sér získný od 80 psů rozdělených do 4 skupin podle následujícího schématu: I) psi s pozitivním výsledkem ANA testu (ANA+) trpící ortopedickým nebo komplexním onemocněním; II) psi s negativním výsledkem ANA testu (ANA-) trpící ortopedickým nebo komplexním onemocněním; III) psi s negativním výsledkem ANA testu (ANA-) s chronickým zánětlivým onemocněním; IV) zdraví kontolní psi. Uvedené skupiny vykázaly statisticky signifikantní rozdíly mezi průměrnými hodnotami RF-IgM. Nejvyšších průměrných hodnot RF-IgM dosáhli psi ze skupin I) a II) a tyto hodnoty byly signifikantně vyšší než hodnoty III) a IV) skupiny, avšak i rozdíly mezi skupinami III) a IV) byly statisticky významné.
Výsledky naší studie potvrzují, že tato metoda je vhodná pro využití ve veterinární laboratorní praxi.
